# Neurology Neuroimmunology & Neuroinflammation

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/neurology-neuroimmunology-and-neuroinflammation/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 2332-7812 |
| ISSNs | 2332-7812 |
| OpenAlex ID | https://openalex.org/S2764892302 |
| Publisher | Wolters Kluwer |

## Journal papers

- [IgLON5 antibody](https://scholariq.org/papers/iglon5-antibody/)
- [Apheresis therapies for NMOSD attacks](https://scholariq.org/papers/apheresis-therapies-for-nmosd-attacks/)
- [Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis](https://scholariq.org/papers/autoantibodies-to-mog-in-a-distinct-subgroup-of-adult-multiple-sclerosis/)
- [Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors](https://scholariq.org/papers/increased-frequency-of-anti-ma2-encephalitis-associated-with-immune-checkpoint/)
- [Anti-NMDAR encephalitis](https://scholariq.org/papers/anti-nmdar-encephalitis/)
- [HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease](https://scholariq.org/papers/hla-and-microtubule-associated-protein-tau-h1-haplotype-associations-in-anti/)
- [Randomized phase 2 trial of NP001, a novel immune regulator](https://scholariq.org/papers/randomized-phase-2-trial-of-np001-a-novel-immune-regulator/)
- [Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease](https://scholariq.org/papers/selected-csf-biomarkers-indicate-no-evidence-of-early-neuroinflammation-in/)
- [Central Vein Sign, Cortical Lesions, and Paramagnetic Rim Lesions for the Diagnostic and Prognostic Workup of Multiple Sclerosis](https://scholariq.org/papers/central-vein-sign-cortical-lesions-and-paramagnetic-rim-lesions-for-the/)
- [Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients](https://scholariq.org/papers/cytokine-profiles-show-heterogeneity-of-interferon-response-in-multiple/)
- [Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy](https://scholariq.org/papers/multiple-sclerosis-disease-activity-and-disability-following-cessation-of/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.